Background Pancreaticobiliary malignancy (PBM) is a group of cancers affecting pancreas and bile duct. The diagnosis is often late and with fatal outcomes. Here, investigators study the clinicodemographic profile of the patients with suspected PBM undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) at a tertiary care center in Nepal. Material and Methods Retrospectively, a descriptive cross-sectional study was conducted at the endoscopy unit of the Internal medicine department of Dhulikhel Hospital-Kathmandu University Hospital (DH-KUH) from Jan 2017 to Jan 2023. Patients over 18 years of age with suspected PBM with complete medical records who underwent ERCP were included in our study. The descriptive and correlation statistics were done.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Measurement of risk factors in patients with Pancreaticobiliary Malignancy
Timeframe: 6 years from January 2017 to January 2023.
Measurement of clinical patterns in patients with Pancreaticobiliary Malignancy
Timeframe: 6 years from January 2017 to January 2023.
Measurement of treatment modalities in patients with Pancreaticobiliary Malignancy
Timeframe: 6 years from January 2017 to January 2023.